Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
Sponsor: M.D. Anderson Cancer Center
Summary
This trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich diet may increase the levels of magnesium in the blood and help prevent hypomagnesemia resulting from carboplatin chemotherapy.
Official title: Feasibility of Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Ovarian Cancer Patients Receiving Carboplatin Chemotherapy
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2019-04-23
Completion Date
2026-04-01
Last Updated
2026-02-17
Healthy Volunteers
No
Conditions
Interventions
Dietary Intervention
Receive dietary magnesium intervention
Media Intervention
Undergo video interviews
Telephone-Based Intervention
Receive phone calls
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States